Technical Reviews: MVIS, CTIC, NEXM
Cell Therapeutics, Inc. (NASDAQ:CTIC), NexMed, Inc. (NASDAQ:NEXM), and Microvision, Inc. (NASDAQ:MVIS) are poked and prodded for trade-worthiness.
| Penny Stock Analysis |
Cell Therapeutics, Inc. (NASDAQ:CTIC), NexMed, Inc. (NASDAQ:NEXM), and Microvision, Inc. (NASDAQ:MVIS) are poked and prodded for trade-worthiness.
Washington Mutual, Inc. (OTC:WAMUQ), Repros Therapeutics Inc. (NASDAQ:RPRX), and Medical Connections Holdings Inc. (OTC:MCTH) are on the trading hot seat.
Kodiak Energy Inc. (OTC:KDKN), Soligenix, Inc. (OTC:SNGX), and Generex Biotechnology Corporation (NASDAQ:GNBT) are run through the trading wringer.
NanoViricides, Inc. (OTC:NNVC), Pacific Biometrics, Inc. (OTC:PBME), and Paid, Inc. (OTC:PAYD) are sliced and diced.
American Oil & Gas Inc. (AMEX:AEZ) and Washington Mutual, Inc. (OTC:WAMUQ) are put under the trading microscope.
Charts of Power3 Medical Products, Inc. (OTC:PWRM), KAT Exploration, Inc. (OTC:KATX), and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) are run through the trading wringer.
MedClean Technologies Inc. (OTC:MCLN), Biomoda, Inc. (OTC:BMOD), and DARA BioSciences, Inc. (NASDAQ:DARA) are poked and prodded for trade-worthiness.
Midex Gold Corp. (OTC:MXGD), SGD Holdings, Ltd. (PINK:SGDH), and Advantage Oil & Gas Ltd. (NYSE:AAV) are rated for trading potential.
First State Bancorp., NM (NASDAQ:FSNM), Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), and KAT Exploration, Inc. (OTC:KATX) are rated and reviewed.
Rainier Pacific Financial Group, Inc. (NASDAQ:RPFG), Trans-Lux Corporation (AMEX:TLX), and Cascade Bancorp (NASDAQ:CACB) are run through the trading wringer.